C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 213/76 (2006.01) A61K 31/395 (2006.01) C07D 231/42 (2006.01) C07D 233/88 (2006.01) C07D 237/20 (2006.01) C07D 239/42 (2006.01) C07D 239/69 (2006.01) C07D 241/22 (2006.01) C07D 249/02 (2006.01) C07D 261/16 (2006.01) C07D 263/50 (2006.01) C07D 275/03 (2006.01) C07D 277/82 (2006.01)
Patent
CA 2123697
A compound of the formula Het-NR-SO2-Ph2-A-Ph1 (COOH)(OH) and tautomic form, salts, solvates, C1-6 alkyl esters and pharmaceutical compositions of the compound. Ph1 and Ph2 are benzene rings with the proviso that carboxy and hy- droxy are ortho to one another. Het includes an optionally substituted heterocyclic ring which includes conjugated double bonds and binds to nitrogen in NR. The compound is characterized in that A is a bridge which is stable against reduction because it is not azo, and in that R is hydrogen or lower alkyl. The invention also includes the preparation of the compound and its use as a drug, particularly for treating autoimmune diseases.
Agback Karl Hubert
Ahrgren Leif
Berglindh Thomas
Haraldsson Martin
Olsson Lars-Inge
Kabi Pharmacia Ab
Pharmacia Aktiebolag
Ridout & Maybee Llp
LandOfFree
Novel substituted salicylic acids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel substituted salicylic acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel substituted salicylic acids will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1942007